http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0767700-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17b678b54e681759b8326f0c3c2ef951
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-14022
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1036
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 1994-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c22421a722eb33b4daa67428f97972e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed40da09cc7af7316251bc28acbe025f
publicationDate 1995-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0767700-A
titleOfInvention HTLV test using synthetic peptides
abstract (57) [Summary] [Structure] Cys-His-Glu-Val-Asp- Lys-Asp-Ile-Ser-Gln-Leu-G ly, Cys-Ala-Gln-Asn-Arg-Ar g-Gly-Leu-Asp-Leu-Leu-Gl y, Cys-Ile-Leu-Gln-Glu-Arg -Pro-Pro-Leu-Glu-Asn-Gly, Peptides selected from the group consisting of any of the actual determinants described above that react with naturally occurring human immunoglobulins, and combinations of said peptides are used to detect HTLV-specific antibodies in patient serum samples. How to detect. [Effect] HTLV in a serum sample of a patient can be detected with high sensitivity.
priorityDate 1984-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397476

Total number of triples: 38.